Biocontrol Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biocontrol Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Craig Slotoroff who wrote ()	11/27/1996 10:46:00 AM
From: Michael Kaufman	of 100

Full text of BICO press release today. Looks like their getting nervous about their stock price. There has been no movement yet (as of 10:45 am), so maybe folks are getting wise to them and they will really have to do the study. --------------------------------------------------------------- PITTSBURGH, Nov. 27 /PRNewswire/ -- Biocontrol Technology Inc announced today that it is continuing communication with the Food and Drug Administration (FDA) to finalize an understanding between the FDA and the Company to do an in-home study on the Diasensor 1000(TM) noninvasive glucose sensor for diabetics. Chief Executive Officer Fred E. Cooper stated, "Once the details are worked out, the Company will commence the study. Although there are no guarantees, it is our hope that this study can be done in a timely fashion." Biocontrol is continuing with its ongoing 510(k) submission process. Once the study has been completed, the Company will resubmit the 510(k) for approval to market the Diasensor 1000 in the United States. Biocontrol Technology, Inc. has its corporate offices in Pittsburgh, Pa., and is involved in the development and manufacture of biomedical devices and environmental products. SOURCE Biocontrol Technology, Inc.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next